93 filings
8-K
BMEA
Biomea Fusion Inc
7 Jun 24
Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
4:02pm
8-K
BMEA
Biomea Fusion Inc
2 May 24
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
4:12pm
10-Q
2024 Q1
BMEA
Biomea Fusion Inc
Quarterly report
2 May 24
4:05pm
ARS
2023 FY
BMEA
Biomea Fusion Inc
26 Apr 24
Annual report to shareholders
4:07pm
DEF 14A
BMEA
Biomea Fusion Inc
Definitive proxy
26 Apr 24
4:01pm
8-K
ifhx1o
1 Apr 24
Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219
4:06pm
8-K
3mtnd1b9eooxqa1
1 Apr 24
Biomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
4:05pm
8-K
40n3a
7 Mar 24
Other Events
4:02pm
8-K
il3bex kv0c
10 Jan 24
Other Events
4:06pm
S-8
ahi f8tgit86s
5 Jan 24
Registration of securities for employees
4:02pm
8-K
vj0d5u4 2pkwx1
30 Oct 23
Biomea Fusion Reports Third Quarter 2023 Financial Results and Corporate Highlights
4:05pm
8-K
1idzy1g k9c9
31 Jul 23
Biomea Fusion Reports Second Quarter 2023 Financial Results and Corporate Highlights
4:08pm
8-K
qjfpgp9yn7ub0c4 rhew
25 Jul 23
BMF-219 Induces Complete Responses in Target Acute Myeloid Leukemia (AML) Patient Population
4:05pm
8-K
s9p49vjd9 8j3l83z
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
cqxt8iw4 kn
2 May 23
Other Events
5:01pm
8-K
x6z4hsehu 6ngbtqj1or
2 May 23
Biomea Fusion Reports First Quarter 2023 Financial Results and Corporate Highlights
4:11pm